Predictive power of glycated hemoglobin in detecting severity of coronary artery disease in non-diabetic patients: A cross-sectional study in southern Iran
- PMID: 39717165
- PMCID: PMC11663445
- DOI: 10.48305/arya.2024.42463.2936
Predictive power of glycated hemoglobin in detecting severity of coronary artery disease in non-diabetic patients: A cross-sectional study in southern Iran
Abstract
Background: The relationship between hemoglobin A1c (HbA1c) levels and coronary artery disease (CAD) severity is still a matter of debate in non-diabetic patients. This study aimed to determine the association between HbA1c and the severity of CAD in non-diabetic patients.
Methods: The present cross-sectional study was conducted in 2018-2019 on 133 non-diabetic patients with stable angina, unstable angina, or myocardial infarction (MI). They were selected through systematic random sampling. The data were collected by taking a complete medical history, calculating the SYNTAX score, and measuring HbA1c.
Results: A SYNTAX score of >22 was significantly correlated with age, left ventricular ejection fraction, HbA1c, and total cholesterol. The mean SYNTAX score was higher in male patients, those with HbA1c >5.6, and patients with a primary clinical presentation of MI. The association between the SYNTAX score and HbA1c was found to be statistically significant (r = 0.659; P < .001). The odds of having a SYNTAX score of >22 for those with HbA1c >5.6 was 5.48 times higher than for those with HbA1c ≤ 5.6 (odds ratio [OR], 5.48; P < .001). The odds of three-vessel disease in individuals with an HbA1c level greater than 5.6 were found to be 4.80 times higher than in those with HbA1c levels at or below 5.6 (OR, 4.80; P = 0.002).
Conclusion: The present findings showed that HbA1c has the potential to predict the severity of CAD in non-diabetic individuals. HbA1c, even at levels within the normal range, was significantly correlated with SYNTAX scores.
Keywords: Coronary artery disease; Diabetes mellitus; Glycated hemoglobin; Iran; SYNTAX score.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
The Association between Hemoglobin A1c and the Severity of Coronary Artery Disease in Non-diabetic Patients with Acute Coronary Syndrome.Cureus. 2020 Jan 12;12(1):e6631. doi: 10.7759/cureus.6631. Cureus. 2020. PMID: 32064206 Free PMC article.
-
Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.Clin Res Cardiol. 2014 Mar;103(3):223-7. doi: 10.1007/s00392-013-0641-7. Epub 2013 Nov 24. Clin Res Cardiol. 2014. PMID: 24271460
-
Glycated Hemoglobin (HbA1c) Correlation with Severity of Coronary Artery Disease in Non-diabetic Patients - A Hospital based Study from North-Eastern India.J Clin Diagn Res. 2016 Sep;10(9):OC20-OC23. doi: 10.7860/JCDR/2016/22378.8525. Epub 2016 Sep 1. J Clin Diagn Res. 2016. PMID: 27790487 Free PMC article.
-
Association Between Glycated Hemoglobin and Severity of Coronary Artery Disease in Type 2 Diabetic Patients With Myocardial Infarction.Cureus. 2025 Mar 31;17(3):e81521. doi: 10.7759/cureus.81521. eCollection 2025 Mar. Cureus. 2025. PMID: 40308397 Free PMC article.
-
Serum glycated albumin is superior to hemoglobin A1c for correlating with HMGB1 in coronary artery disease with type 2 diabetic mellitus patients.Int J Clin Exp Med. 2015 Apr 15;8(4):4821-5. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131056 Free PMC article. Review.
References
-
- WHO. Cardiovascular diseases (CVDs): fact sheet. World Health Organization; 2021.
-
- Brown JC, Gerhardt TE, Kwon E. StatPearls. Treasure Island (FL) ineligible companies; 2023. Risk Factors for Coronary Artery Disease. - PubMed
-
- Sarrafzadegan N, Mohammmadifard N. Cardiova-scular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Arch Iran Med. 2019 Apr;22(4):204–10. - PubMed
-
- Nikparvar M, Farshidi H, Madani A, Azad M, Eftekhaari TE, Ghanbarnejad A, et al. Prevalence, awareness, treatment, and control of hypertension in Hormozgan Province, Iran. Int Cardiovasc Res J. 2019;13(3):91–5.
LinkOut - more resources
Full Text Sources
Miscellaneous